Compile Data Set for Download or QSAR
maximum 50k data
Found 33 Enz. Inhib. hit(s) with Target = 'Apoptosis regulator Bcl-2 [1-204]'
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM204936(US9248140, 20)
Affinity DataIC50:  0.300nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156377(US9018381, 2 | US9248140, 2)
Affinity DataIC50:  0.300nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156378(US9018381, 3 | US9248140, 3)
Affinity DataIC50: <0.300nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM204937(US9248140, 21)
Affinity DataIC50:  0.300nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156401(US9018381, 24 | US9248140, 24)
Affinity DataIC50:  0.400nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156402(US9018381, 25 | US9248140, 25)
Affinity DataIC50:  0.400nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156403(US9018381, 26 | US9248140, 26)
Affinity DataIC50:  0.400nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156380(US9018381, 4 | US9248140, 4)
Affinity DataIC50:  0.5nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156399(US9018381, 22 | US9248140, 22)
Affinity DataIC50:  0.600nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156387(US9018381, 10 | US9248140, 10)
Affinity DataIC50:  0.700nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156382(US9018381, 5 | US9248140, 5)
Affinity DataIC50:  0.800nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156393(US9018381, 16 | US9248140, 16)
Affinity DataIC50:  0.800nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156385(US9018381, 8 | US9248140, 8)
Affinity DataIC50:  0.900nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156386(US9018381, 9 | US9248140, 9)
Affinity DataIC50:  0.900nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156400(US9018381, 23 | US9248140, 23)
Affinity DataIC50:  1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156376(US9018381, 1 | US9248140, 1)
Affinity DataIC50: <1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156407(US9018381, 30 | US9248140, 30)
Affinity DataIC50:  1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156383(US9018381, 6 | US9248140, 6)
Affinity DataIC50:  1nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156384(US9018381, 7 | US9248140, 7)
Affinity DataIC50:  2nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156394(US9018381, 17 | US9018381, 18 | US9248140, 18)
Affinity DataIC50:  2nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156389(US9018381, 12 | US9248140, 12)
Affinity DataIC50:  3nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156392(US9018381, 15 | US9248140, 15)
Affinity DataIC50:  3nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156405(US9018381, 28 | US9248140, 28)
Affinity DataIC50:  4nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156388(US9018381, 11 | US9248140, 11)
Affinity DataIC50:  4nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156394(US9018381, 17 | US9018381, 18 | US9248140, 18)
Affinity DataIC50:  7nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156390(US9018381, 13 | US9248140, 13)
Affinity DataIC50:  16nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156413(US9018381, 36 | US9248140, 36)
Affinity DataIC50:  24nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156411(US9018381, 34 | US9248140, 34)
Affinity DataIC50:  27nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156406(US9018381, 29 | US9248140, 29)
Affinity DataIC50:  30nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156410(US9018381, 33 | US9248140, 33)
Affinity DataIC50:  30nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156412(US9018381, 35 | US9248140, 35)
Affinity DataIC50:  38nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156391(US9018381, 14 | US9248140, 14)
Affinity DataIC50:  253nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2 [1-204](Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM156396(US9018381, 19 | US9248140, 19)
Affinity DataIC50:  1.20E+3nMpH: 7.5Assay Description:Bcl-xL and Bcl-2 FP binding affinity of compound(s) of Formulae (I), (I-a), (I-b), (I-c), (I-d) and/or (I-c) may be determined using a variety of kno...More data for this Ligand-Target Pair
In DepthDetails US Patent